CJC No DAC/Ipamorelin Blend

CJC-1295 / Ipamorelin Blend (GHRH Analogue / Selective GHRP)

CJC-1295 / Ipamorelin is a synthetic peptide blend combining two distinct compounds that act on the growth hormone secretion pathway. CJC-1295 is a growth hormone-releasing hormone (GHRH) analogue, while Ipamorelin is a selective growth hormone-releasing peptide (GHRP). Together, they are studied for their synergistic influence on growth hormone signaling in research models.

In research contexts, scientists are investigating this blend for its potential role in growth hormone pulse amplification, cellular regeneration signaling, metabolic function, and age-related hormonal changes. Studies have also explored its effects on sleep regulation, nitrogen retention, and IGF-1 expression in controlled laboratory environments.

FDA DISCLAIMER: CJC/Ipamorelin supplied by AMYNO is intended strictly for laboratory and scientific research purposes. It is not approved by the Food and Drug Administration (FDA) for human or animal use, and is not intended to diagnose, treat, cure, or prevent any disease or medical condition. All research involving this compound should be conducted by qualified professionals in a controlled setting and in compliance with all applicable laws and regulations.